Search research articles
Contact Us
Filters
Showing results (161-170 of 225) with videos related to
Page
of 23
Sort By:
European Journal of Clinical Pharmacology
|
January 1, 1985
Antipyrine metabolite formation and excretion in patients with chronic renal failure
M W Teunissen, D Kampf, I Roots, et al.
Chemical Research in Toxicology
|
December 22, 1998
Prediction of aryl hydrocarbon receptor-mediated enzyme induction of drugs and chemicals by mRNA quantification
R Frötschl, L Chichmanov, U Kleeberg, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
August 22, 2001
Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirus/insect cell system
D Schwarz, P Kisselev, H Honeck, et al.
Pharmacopsychiatry
|
October 29, 1997
Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans
J Brockmöller, T Reum, S Bauer, et al.
Trends in Pharmacological Sciences
|
November 1, 1994
Comments from chairs of institutes of clinical pharmacology in Germany
J C Frölich, W P Kirch, N Rietbrock, et al.
Neurology
|
June 11, 2003
L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism
R Kaiser, A Hofer, A Grapengiesser, et al.
The Journal of Clinical Investigation
|
January 15, 1996
Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis
F G Mastronardi, B Mak, C A Ackerley, et al.
Klinische Wochenschrift
|
April 17, 1989
Cyclosporin drug monitoring: comparison of four immunoassays and HPLC
U Kunzendorf, J Brockmöller, F Jochimsen, et al.
Transplantation
|
June 1, 1991
Promotion of B cell stimulation in graft recipients through a mechanism distinct from interleukin-6 gene superinduction
U Kunzendorf, J Brockmöller, U Bickel, et al.
Journal of Neuroscience Research
|
October 15, 1993
Demyelination in a transgenic mouse: a model for multiple sclerosis
F G Mastronardi, C A Ackerley, L Arsenault, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 225) with videos related to
Sort By:
Page
of 23
European Journal of Clinical Pharmacology
|
January 1, 1985
Antipyrine metabolite formation and excretion in patients with chronic renal failure
M W Teunissen, D Kampf, I Roots, et al.
Chemical Research in Toxicology
|
December 22, 1998
Prediction of aryl hydrocarbon receptor-mediated enzyme induction of drugs and chemicals by mRNA quantification
R Frötschl, L Chichmanov, U Kleeberg, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
August 22, 2001
Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirus/insect cell system
D Schwarz, P Kisselev, H Honeck, et al.
Pharmacopsychiatry
|
October 29, 1997
Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans
J Brockmöller, T Reum, S Bauer, et al.
Trends in Pharmacological Sciences
|
November 1, 1994
Comments from chairs of institutes of clinical pharmacology in Germany
J C Frölich, W P Kirch, N Rietbrock, et al.
Neurology
|
June 11, 2003
L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism
R Kaiser, A Hofer, A Grapengiesser, et al.
The Journal of Clinical Investigation
|
January 15, 1996
Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis
F G Mastronardi, B Mak, C A Ackerley, et al.
Klinische Wochenschrift
|
April 17, 1989
Cyclosporin drug monitoring: comparison of four immunoassays and HPLC
U Kunzendorf, J Brockmöller, F Jochimsen, et al.
Transplantation
|
June 1, 1991
Promotion of B cell stimulation in graft recipients through a mechanism distinct from interleukin-6 gene superinduction
U Kunzendorf, J Brockmöller, U Bickel, et al.
Journal of Neuroscience Research
|
October 15, 1993
Demyelination in a transgenic mouse: a model for multiple sclerosis
F G Mastronardi, C A Ackerley, L Arsenault, et al.
Page
of 23